Putrescine and method to reduce risk of aneuploid pregnancy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9248108
APP PUB NO 20150224068A1
SERIAL NO

14422598

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A medicament for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ornithine decarboxylase (ODC) activity level, the medicament includes putrescine. A use of putrescine for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels. A method for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels by administering putrescine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OTTAWA HOSPITAL RESEARCH INSTITUTEOTTAWA ON K1N 6N5

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liu, Xingquan Johné Ottawa, CA 1 0
Tao, Yong Ottawa, CA 52 96

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 2, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00